Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: acceptable well-documented publication which meets basic scientific principles

Data source

Reference
Reference Type:
publication
Title:
Skin sensitization potency and cross-reactivity of p-phenylenediamine and its derivatives evaluated by non-radioactive murine local lymph node assay and guinea-pig maximization test
Author:
Yamano, T. et al.
Year:
2009
Bibliographic source:
Contact Dermatitis, 60, 193-198

Materials and methods

Principles of method if other than guideline:
other: Guinea pig maximization test according to Nakamura A. et al. (1994) Contact Dermatitis, 31, 72-85
GLP compliance:
not specified
Remarks:
The study is an academic publication and often the GLP status is not specified.
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The study was conducted before the requirement for the LLNA

Test material

Constituent 1
Chemical structure
Reference substance name:
N-1,3-dimethylbutyl-N'-phenyl-p-phenylenediamine
EC Number:
212-344-0
EC Name:
N-1,3-dimethylbutyl-N'-phenyl-p-phenylenediamine
Cas Number:
793-24-8
Molecular formula:
C18H24N2
IUPAC Name:
N1-(4-methylpentan-2-yl)-N4-phenylbenzene-1,4-diamine
Details on test material:
N-(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine (DMBPPD)

In vivo test system

Test animals

Species:
guinea pig
Strain:
Hartley
Sex:
female

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
other: acetone
Concentration / amount:
induction (intradermal and topical: 500 ppm, challenge: 50 ppm and 5000 ppm
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
other: acetone
Concentration / amount:
induction (intradermal and topical: 500 ppm, challenge: 50 ppm and 5000 ppm
No. of animals per dose:
4

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50 ppm
No. with + reactions:
4
Total no. in group:
4
Clinical observations:
positive skin reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50 ppm. No with. + reactions: 4.0. Total no. in groups: 4.0. Clinical observations: positive skin reaction.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
5000 ppm
No. with + reactions:
4
Total no. in group:
4
Clinical observations:
positive skin reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 5000 ppm. No with. + reactions: 4.0. Total no. in groups: 4.0. Clinical observations: positive skin reaction.

Any other information on results incl. tables

DMBPPD was positive in the guinea pig maximation test; at 50 ppm (0.005 %) and 5000 ppm (0.5%)( 4/4 treated animals showed positive skin reactions.

Potency category based on GPMT: strong

Applicant's summary and conclusion

Interpretation of results:
sensitising
Remarks:
Migrated information